Ozempic: How 'mercenary' start-up Eucalyptus scored $100m selling breakout drug

Eucalyptus could have been a Millennial house of brands but instead it hitched its wagon to the breakout drug of 2023, triggering controversy and sales.

Related Keywords

Japan ,Germany ,United Kingdom ,Australia ,Australian ,Australians ,Charlie Gearside ,Nicole Higgins ,Tim Doyle ,Alexey Mitko ,Nick Crocker ,Benny Kleist ,Michael Quelch ,Eli Lilly ,Christopher Nolan ,Nick Coatsworth ,Alex Ellinghausen ,Australian National University ,Louis Vuitton Moet Hennessy ,Drug Administration ,Novo Nordisk ,Therapeutic Goods Administration ,Royal Australian College ,Australian Institute Of Health ,Professor Christopher Nolan ,Blackbird Ventures ,Australian Institute ,General Practitioners ,Medical Board ,